← Eichor
Study identifier: NCT04402151 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Study of PSMA PET/MR Guided Stereotactic Body Radiation Therapy With Simultaneous Integrated Boost (SBRT-SIB) for High-Intermediate and High Risk Prostate Cancer

Condition: Prostate Cancer  ·  Sponsor: Weill Medical College of Cornell University

PhasePhase 2
Planned participants50
Who can joinMale, 21 Years to 90 Years
Healthy volunteersNo

About this study

This is a single-arm Phase II clinical trial assessing the clinical efficacy of prostate specific membrane antigen (PSMA) PET/MR guided MR-LINAC based SBRT-SIB with planned accrual of 50 patients.

This description comes directly from the study's public registry record.

Talk to the study team

Fabiana Gregucci, M.D.  ·  646-962-3110  ·  fgr4002@med.cornell.edu

Dakota Trick  ·  646-962-3118  ·  dat4015@med.cornell.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Weill Cornell MedicineNew York, New York, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04402151